 |
PDBsum entry 1ucp
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
332:1155-1163
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition.
|
|
E.Liepinsh,
R.Barbals,
E.Dahl,
A.Sharipo,
E.Staub,
G.Otting.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The PYRIN domain is a conserved sequence motif identified in more than 20 human
proteins with putative functions in apoptotic and inflammatory signalling
pathways. The three-dimensional structure of the PYRIN domain from human ASC was
determined by NMR spectroscopy. The structure determination reveals close
structural similarity to death domains, death effector domains, and caspase
activation and recruitment domains, although the structural alignment with these
other members of the death-domain superfamily differs from previously predicted
amino acid sequence alignments. Two highly positively and negatively charged
surfaces in the PYRIN domain of ASC result in a strong electrostatic dipole
moment that is predicted to be present also in related PYRIN domains. These
results suggest that electrostatic interactions play an important role for the
binding between PYRIN domains. Consequently, the previously reported binding
between the PYRIN domains of ASC and ASC2/POP1 or between the zebrafish PYRIN
domains of zAsc and Caspy is proposed to involve interactions between helices 2
and 3 of one PYRIN domain with helices 1 and 4 of the other PYRIN domain, in
analogy to previously reported homophilic interactions between caspase
activation and recruitment domains.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Amino acid sequence alignment of PYRIN domains,
PYRIN domain structure and distribution of charged residues. A,
Amino acid sequence alignment of 35 PYRIN domains from human and
mouse and two from zebrafish. The PYRIN domain of ASC is shown
at the top, together with its sequence numbering. The amino acid
sequence of the FADD DED domain is shown at the bottom for
comparison. The location of the helices and buried side-chains
with less than 5% solvent exposure is indicated for the ASC
PYRIN domain and the FADD DED domain by bars and filled squares,
respectively. Arrows identify positions of significant
differences between the PYRIN domains and the DED consensus. The
consensus sequence of PYRIN domains is indicated below the PYRIN
sequences, where upper case letters indicate conservation of
distinct amino acids and lower case letters indicate
conservation of (h)ydrophobic, (c)harged, (p)olar, a(l)iphatic,
and (t)iny amino acid side-chains. Consensus characters were
assigned when >80% of the residues of a column belong to the
same amino acid class. hs, Homo sapiens; mm, Mus musculus;
PYRIN, pyrin protein; z, zebrafish; ASC, apoptosis-associated
speck-like protein containing a CARD; POP1, pyrin-only protein
1; CIAS1, cold autoinflammatory syndrome 1 (also called PYPAF1
or cryopyrin); CRYOPYR_11, cryopyrin-like protein 1; NALP2,
NACHT-, LRR-, and PYD-containing protein 2 (also called PYPAF2);
NLP2_l1, NALP2-like protein 1; NLP3_l1, NALP3-like protein 1;
PYPAF1-7: PYRIN-containing APAF1-like protein 1-7; PYPAF4_l1-3,
PYPAF4 like proteins 1, 2 and 3; DEFCAP, death effector
filament-forming Ced-4-like apoptosis protein; IFI16, interferon
gamma-inducible protein 16; IFI16_l1-2, IFI16-like proteins 1
and 2; IFI203 and IFI204, interferon-activatable proteins 203
and 204; MNDA, myeloid cell nuclear differentiation antigen;
AIM2, absent in melanoma 2; MATER,
maternal-antigen-that-embryos-require; ANGIN2_l1-3, angiogenin
inhibitor 2-like proteins 1-3; MCMI1, mast cell
maturation-inducible protein-like protein; DKFZ, predicted
protein from DKFZ institute transcript; ENSMUSP00000038294 and
ENSMUSP00000048095: hypothetical proteins predicted by the
ENSEMBL genome annotation project. hs_POP1 is also called
ASC2.[30. and 46.]
|
 |
Figure 4.
Figure 4. PYRIN domain structure and distribution of
charged residues. (a) Stereo view of a superposition of the
backbone atoms in the 20 conformers representing the NMR
structure of the ASC PYRIN domain (Table 1). Numbers identify
sequence positions. (b) Stereo view of the conformer closest to
the mean structure of the 20 conformers shown in (a). The
following colors were used for the side-chains: blue, Arg, Lys,
His; red, Glu, Asp; yellow, Ala, Cys, Ile, Leu, Met, Phe, Pro,
Trp, Val; grey, Asn, Gln, Ser, Thr, Tyr. Bold lines identify
charged side-chains of Arg, Lys, Asp and Glu. The molecule is
oriented so that most of the negatively and positively charged
side chains are located, respectively, in the left and right
half of the molecule. (c) and (d) Ribbon drawing of the PYRIN
domain. Spheres identify the positions of C^a atoms, where
positively (blue) and negatively (red) charged side-chains are
located in the zebrafisch PYRIN domains of zAsc (c) and Caspy
(d). The six helices are numbered.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2003,
332,
1155-1163)
copyright 2003.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
N.B.Bryan,
A.Dorfleutner,
S.J.Kramer,
C.Yun,
Y.Rojanasakul,
and
C.Stehlik
(2010).
Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes.
|
| |
J Inflamm (Lond),
7,
23.
|
 |
|
|
|
|
 |
S.Celik,
A.A.Erikci,
Y.Tunca,
O.Sayan,
H.M.Terekeci,
E.E.Umur,
D.Torun,
F.Tangi,
C.Top,
and
C.Oktenli
(2010).
The rate of MEFV gene mutations in hematolymphoid neoplasms.
|
| |
Int J Immunogenet,
37,
387-391.
|
 |
|
|
|
|
 |
E.de Alba
(2009).
Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC).
|
| |
J Biol Chem,
284,
32932-32941.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.J.Chae,
I.Aksentijevich,
and
D.L.Kastner
(2009).
Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.
|
| |
Br J Haematol,
146,
467-478.
|
 |
|
|
|
|
 |
K.Matsushita,
M.Takeoka,
J.Sagara,
N.Itano,
Y.Kurose,
A.Nakamura,
and
S.Taniguchi
(2009).
A splice variant of ASC regulates IL-1beta release and aggregates differently from intact ASC.
|
| |
Mediators Inflamm,
2009,
287387.
|
 |
|
|
|
|
 |
M.Proell,
S.J.Riedl,
J.H.Fritz,
A.M.Rojas,
and
R.Schwarzenbacher
(2008).
The Nod-like receptor (NLR) family: a tale of similarities and differences.
|
| |
PLoS ONE,
3,
e2119.
|
 |
|
|
|
|
 |
T.Srimathi,
S.L.Robbins,
R.L.Dubas,
H.Chang,
H.Cheng,
H.Roder,
and
Y.C.Park
(2008).
Mapping of POP1-binding site on pyrin domain of ASC.
|
| |
J Biol Chem,
283,
15390-15398.
|
 |
|
|
|
|
 |
Z.Gattin,
and
W.F.van Gunsteren
(2008).
A molecular dynamics study of the ASC and NALP1 pyrin domains at neutral and low pH.
|
| |
Chembiochem,
9,
923-933.
|
 |
|
|
|
|
 |
Z.Ye,
and
J.P.Ting
(2008).
NLR, the nucleotide-binding domain leucine-rich repeat containing gene family.
|
| |
Curr Opin Immunol,
20,
3-9.
|
 |
|
|
|
|
 |
A.Dorfleutner,
N.B.Bryan,
S.J.Talbott,
K.N.Funya,
S.L.Rellick,
J.C.Reed,
X.Shi,
Y.Rojanasakul,
D.C.Flynn,
and
C.Stehlik
(2007).
Cellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activation.
|
| |
Infect Immun,
75,
1484-1492.
|
 |
|
|
|
|
 |
A.Dorfleutner,
S.J.Talbott,
N.B.Bryan,
K.N.Funya,
S.L.Rellick,
J.C.Reed,
X.Shi,
Y.Rojanasakul,
D.C.Flynn,
and
C.Stehlik
(2007).
A Shope Fibroma virus PYRIN-only protein modulates the host immune response.
|
| |
Virus Genes,
35,
685-694.
|
 |
|
|
|
|
 |
H.H.Park,
Y.C.Lo,
S.C.Lin,
L.Wang,
J.K.Yang,
and
H.Wu
(2007).
The death domain superfamily in intracellular signaling of apoptosis and inflammation.
|
| |
Annu Rev Immunol,
25,
561-586.
|
 |
|
|
|
|
 |
I.Aksentijevich,
C.D Putnam,
E.F.Remmers,
J.L.Mueller,
J.Le,
R.D.Kolodner,
Z.Moak,
M.Chuang,
F.Austin,
R.Goldbach-Mansky,
H.M.Hoffman,
and
D.L.Kastner
(2007).
The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.
|
| |
Arthritis Rheum,
56,
1273-1285.
|
 |
|
|
|
|
 |
L.Quaglietta,
A.te Velde,
A.Staiano,
R.Troncone,
and
D.W.Hommes
(2007).
Functional consequences of NOD2/CARD15 mutations in Crohn disease.
|
| |
J Pediatr Gastroenterol Nutr,
44,
529-539.
|
 |
|
|
|
|
 |
S.Taniguchi,
and
J.Sagara
(2007).
Regulatory molecules involved in inflammasome formation with special reference to a key mediator protein, ASC.
|
| |
Semin Immunopathol,
29,
231-238.
|
 |
|
|
|
|
 |
A.Dursun,
H.G.Durakbasi-Dursun,
A.G.Zamani,
Z.G.Gulbahar,
R.Dursun,
and
C.Yakicier
(2006).
Genetic analysis of MEFV gene pyrin domain in patients with Behçet's disease.
|
| |
Mediators Inflamm,
2006,
41783.
|
 |
|
|
|
|
 |
A.Natarajan,
R.Ghose,
and
J.M.Hill
(2006).
Structure and dynamics of ASC2, a pyrin domain-only protein that regulates inflammatory signaling.
|
| |
J Biol Chem,
281,
31863-31875.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Amini,
M.H.Ahmadi Pour,
and
K.Azadmanesh
(2006).
The phylogenetic analysis of hepatitis C virus isolates obtained from two Iranian carriers revealed evidence for a new subtype of HCV genotype 3.
|
| |
Virus Genes,
33,
271-278.
|
 |
|
|
|
|
 |
Y.Ding,
J.F.Lee,
H.Lu,
M.H.Lee,
and
D.H.Yan
(2006).
Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2.
|
| |
Mol Cell Biol,
26,
1979-1996.
|
 |
|
|
|
|
 |
Inohara,
Chamaillard,
C.McDonald,
and
G.Nuñez
(2005).
NOD-LRR proteins: role in host-microbial interactions and inflammatory disease.
|
| |
Annu Rev Biochem,
74,
355-383.
|
 |
|
|
|
|
 |
J.P.Ting,
and
B.K.Davis
(2005).
CATERPILLER: a novel gene family important in immunity, cell death, and diseases.
|
| |
Annu Rev Immunol,
23,
387-414.
|
 |
|
|
|
|
 |
L.Eckhart,
C.Ballaun,
A.Uthman,
C.Kittel,
M.Stichenwirth,
M.Buchberger,
H.Fischer,
W.Sipos,
and
E.Tschachler
(2005).
Identification and characterization of a novel mammalian caspase with proapoptotic activity.
|
| |
J Biol Chem,
280,
35077-35080.
|
 |
|
|
|
|
 |
S.Stojanov,
and
D.L.Kastner
(2005).
Familial autoinflammatory diseases: genetics, pathogenesis and treatment.
|
| |
Curr Opin Rheumatol,
17,
586-599.
|
 |
|
|
|
|
 |
E.Liepinsh,
M.Rakonjac,
V.Boissonneault,
P.Provost,
B.Samuelsson,
O.Rådmark,
and
G.Otting
(2004).
NMR structure of human coactosin-like protein.
|
| |
J Biomol NMR,
30,
353-356.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Martinon,
and
J.Tschopp
(2004).
Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases.
|
| |
Cell,
117,
561-574.
|
 |
|
|
|
|
 |
J.M.Bruey,
N.Bruey-Sedano,
R.Newman,
S.Chandler,
C.Stehlik,
and
J.C.Reed
(2004).
PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages.
|
| |
J Biol Chem,
279,
51897-51907.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |